Literature DB >> 26756637

Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments.

Sandra Orgeig1, Janna L Morrison1, Christopher B Daniels1.   

Abstract

Surfactant lipids and proteins form a surface active film at the air-liquid interface of internal gas exchange organs, including swim bladders and lungs. The system is uniquely positioned to meet both the physical challenges associated with a dynamically changing internal air-liquid interface, and the environmental challenges associated with the foreign pathogens and particles to which the internal surface is exposed. Lungs range from simple, transparent, bag-like units to complex, multilobed, compartmentalized structures. Despite this anatomical variability, the surfactant system is remarkably conserved. Here, we discuss the evolutionary origin of the surfactant system, which likely predates lungs. We describe the evolution of surfactant structure and function in invertebrates and vertebrates. We focus on changes in lipid and protein composition and surfactant function from its antiadhesive and innate immune to its alveolar stability and structural integrity functions. We discuss the biochemical, hormonal, autonomic, and mechanical factors that regulate normal surfactant secretion in mature animals. We present an analysis of the ontogeny of surfactant development among the vertebrates and the contribution of different regulatory mechanisms that control this development. We also discuss environmental (oxygen), hormonal and biochemical (glucocorticoids and glucose) and pollutant (maternal smoking, alcohol, and common "recreational" drugs) effects that impact surfactant development. On the adult surfactant system, we focus on environmental variables including temperature, pressure, and hypoxia that have shaped its evolution and we discuss the resultant biochemical, biophysical, and cellular adaptations. Finally, we discuss the effect of major modern gaseous and particulate pollutants on the lung and surfactant system.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26756637     DOI: 10.1002/cphy.c150003

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  7 in total

1.  Differential effects of late gestation maternal overnutrition on the regulation of surfactant maturation in fetal and postnatal life.

Authors:  Mitchell C Lock; Erin V McGillick; Sandra Orgeig; I Caroline McMillen; Beverly S Mühlhäusler; Song Zhang; Janna L Morrison
Journal:  J Physiol       Date:  2017-08-24       Impact factor: 5.182

2.  Heterochronic regulation of lung development via the Lin28-Let-7 pathway.

Authors:  Nelly Komarovsky Gulman; Leah Armon; Tali Shalit; Achia Urbach
Journal:  FASEB J       Date:  2019-08-07       Impact factor: 5.191

3.  World health days in May 2020: pulmonary hypertension; asthma; and tobacco-, smoking-, and vaping-related disease in focus.

Authors:  Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-01       Impact factor: 5.464

Review 4.  On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx.

Authors:  Matthias Ochs; Jan Hegermann; Elena Lopez-Rodriguez; Sara Timm; Geraldine Nouailles; Jasmin Matuszak; Szandor Simmons; Martin Witzenrath; Wolfgang M Kuebler
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 5.  Alveolar Dynamics and Beyond - The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis.

Authors:  Kirsten Sehlmeyer; Jannik Ruwisch; Nuria Roldan; Elena Lopez-Rodriguez
Journal:  Front Physiol       Date:  2020-05-05       Impact factor: 4.566

6.  Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model.

Authors:  M Neuhaus; A Munder; J Schipke; A Schmiedl
Journal:  Inflamm Res       Date:  2019-05-14       Impact factor: 4.575

Review 7.  A recipe for a good clinical pulmonary surfactant.

Authors:  Jesús Pérez-Gil
Journal:  Biomed J       Date:  2022-03-08       Impact factor: 7.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.